title: [Comparative study of hepatoprotective action of remaxol, reamberin and ademethionine in liver injury induced by antituberculosis drugs (experimental study)].
abstract: The hepatoprotective activity of remaxol, reamberin and ademethionine was studied on a model of the liver injury induced by antituberculosis drugs. The study included 30 male uninbred albino rats. The following antituberculosis drugs were used: isoniazid (50 mg/kg) subcutaneously + rifampicin (250 mg/kg) intragastrically + pyrazinamide (45 mg/kg) intragastically (by the procedure of Yu. I. Slivka, 1989). Remaxol, reamberin and ademethionine were administered 1.5 hour prior to the antituberculosis drugs. The treatment course was 14 days. It was shown that remaxol, reamberin and ademethionin were able to correct the structural and functional disorders in the liver due to the use of the antituberculosis drugs. By the impact on the biochemical indices, evident of the liver function condition, remaxol showed the maximum effect. The effect of ream-berin was somewhat lower and the results of the ademethionine use were less significant. Remaxol had also a distinct effect as for lowering the level of the structural injuries in the liver, evident from recovery of the organ histoarchitectonics, less extended carbohydrate, albuminous and fatty degeneration, more active intracellular regeneration. It was noted that ademethionine had an insignificant effect on necrobiosis. Moreover, there was once detected a large necrosis focus, evident of possible stimulation of the liver tissue alteration by the drug.
authors.forename: D S
authors.initials: DS
authors.lastname: Sukhanov
authors.forename: T I
authors.initials: TI
authors.lastname: Vinogradova
authors.forename: N V
authors.initials: NV
authors.lastname: Zabolotnykh
authors.forename: A L
authors.initials: AL
authors.lastname: Kovalenko
authors.forename: S N
authors.initials: SN
authors.lastname: Vasil'eva
authors.forename: M G
authors.initials: MG
authors.lastname: Romantsov
mesh_terms: D000818:Animals; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000494:pharmacology; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D008099:Liver / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D008115:Liver Regeneration / Q000187:drug effects*; D008297:Male; D008536:Meglumine / Q000031:analogs & derivatives* / Q000494:pharmacology; D051381:Rats; D012436:S-Adenosylmethionine / Q000494:pharmacology*; D013386:Succinates / Q000494:pharmacology*; D013997:Time Factors
chemical_list: D000995:Antitubercular Agents; C549374:Reamberin; C555877:Remaxol; D013386:Succinates; D008536:Meglumine; D012436:S-Adenosylmethionine